Cuprina Holdings (Cayman) Ltd. (Nasdaq: CUPR), a biomedical and biotechnology company focused on products for chronic wound and infertility management as well as cosmeceuticals, will present at the Skyline Signature Series™ on Wednesday, October 8, 2025, at 11:00 AM ET. The company's management team, including CEO David Quek, will answer questions from investors during the live, interactive online event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings (Cayman) Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9539859-en) on October 06, 2025, and is solely responsible for the information contained therein.